α-Catulin knockdown induces senescence in cancer cells

L-C Fan1, W-F Chiang, C-H Liang

  • 1Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.

Oncogene
|February 1, 2011
PubMed

Insights

α-Catulin promotes tumor growth by preventing cellular senescence. Downregulating α-catulin may be a promising therapeutic approach for cancer treatment, as its depletion induces DNA damage and senescence.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cellular senescence acts as a tumor suppressor.
  • α-Catulin, an α-catenin-related protein, is implicated in tumorigenesis via the nuclear factor-κB (NF-κB) pathway.
  • The clinical relevance and precise mechanism of α-catulin in cancer progression remain unclear.

Purpose of the Study:

  • To investigate the clinical significance of α-catulin in oral squamous cell carcinoma.
  • To elucidate the mechanism by which α-catulin regulates cancer progression and cellular senescence.
  • To explore the therapeutic potential of targeting α-catulin.

Main Methods:

  • Analysis of α-catulin mRNA levels in cancer cell lines and clinical samples.
  • α-Catulin knockdown experiments in OC2 and A549 cancer cell lines.
  • Assessment of cell proliferation, cellular senescence, and xenograft growth.
  • Investigation of the DNA-damage response (DDR) pathways, including p53/p21.
  • Global gene expression analysis to identify affected pathways.

Main Results:

  • α-Catulin mRNA levels were significantly upregulated in oral squamous cell carcinomas and correlated with tumor size and AJCC stage.
  • α-Catulin knockdown reduced cancer cell proliferation, induced cellular senescence, and inhibited tumor growth.
  • α-Catulin depletion triggered the DNA-damage response (DDR) via p53/p21-dependent or -independent pathways.
  • Knockdown altered cell-cycle regulation, DDR pathways, and downregulated genes involved in chromosome condensation and DNA repair.

Conclusions:

  • α-Catulin promotes tumor growth by inhibiting cellular senescence.
  • α-Catulin upregulation is clinically relevant in oral squamous cell carcinoma.
  • Targeting α-catulin represents a potential therapeutic strategy for cancer treatment.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...